Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

6.75
Delayed Data
As of May 25
 +0.28 / +4.33%
Today’s Change
6.17
Today|||52-Week Range
11.93
-17.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$257.9M

Company Description

Avadel Pharmaceuticals Plc develops and manufactures pharmaceutical products. Its hospital products include Bloxiverz, Vazculep and Akovaz. The company's Pediatrics Products include Karbinal ER,Cefaclor, AcipHex Sprinkle and Flexichamber. Avadel Pharmaceuticals was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Contact Information

Avadel Pharmaceuticals Plc
Blanchardstown Corporate Park
Dublin Dublin 15
P:(531) 485-1200
Investor Relations:

Employees

Shareholders

Other institutional52.19%
Individual stakeholders19.76%
Mutual fund holders12.13%

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Gregory J. DivisChief Operating Officer & Executive Vice President
Michael F. KananChief Financial Officer & Senior Vice President
David MonteithVice President-Research & Development
Phillandas T. ThompsonSecretary, Senior Vice President & General Counsel